Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAPL Apple	Target Set by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$256.08 +4.3%	$270.00 ➝ $310.00	Outperform
ABBV AbbVie	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Clark-Gartner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$223.09 +0.3%	$207.00 ➝ $222.00	Outperform
ABX Barrick Gold	Upgraded by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$48.94 +7.4%	C$36.00 ➝ C$51.00	Sector Perform ➝ Outperform
ABX Barrick Gold	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$48.94 +7.4%	C$37.00 ➝ C$41.00
ADRNY Ahold	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		€39.73 +0.1%		Hold ➝ Strong-Buy
AGF.B AGF Management	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$14.31 +0.5%	C$15.00 ➝ C$17.00	Buy
AGX Argan	Initiated by	Glj Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Wang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$268.99 +3.2%	$251.00	Hold
AHEXY Adecco	Upgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.32 +2.8%		Outperform
AII American Integrity Insurance Group	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Peters Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.48 +4.5%	$22.00 ➝ $24.00	Outperform
ALB Albemarle	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.45 -1.7%	$60.00 ➝ $75.00	Hold

AMAT Applied Materials	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$200.52 +5.5%	$172.00 ➝ $209.00	Equal Weight ➝ Overweight
AMCR Amcor	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.27 +0.1%		Sector Perform
ANIX Anixa Biosciences	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.49 +5.8%	$10.00	Buy
AS Amer Sports	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Straton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.36 -5.6%	$41.00	Positive
AS Amer Sports	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.36 -5.6%	$35.00 ➝ $38.00	Equal Weight
ASML ASML	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$957.80 +2.8%		Equal Weight ➝ Overweight
ASML ASML	Upgraded by	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$957.80 +2.8%		Hold ➝ Buy
ATOS Atossa Genetics	Target Raised by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.83 -2.1%	$7.50 ➝ $7.75	Buy
AUGO Aura Minerals	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lawson Winder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.38 +7.5%	$40.00	Buy
AVPT AvePoint	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.75 +0.5%	$20.00
B Barrick Mining	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.37 +7.2%	$30.00 ➝ $38.00	Buy
B Barrick Mining	Target Raised by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anita Soni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.37 +7.2%	$30.00 ➝ $38.00	Outperformer
B Barrick Mining	Reiterated by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anita Soni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.37 +7.2%		Outperform
B Barrick Mining	Upgraded by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.37 +7.2%		Outperform
B Barrick Mining	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Wolfson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.37 +7.2%	$38.00	Outperform
B Barrick Mining	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian MacArthur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.37 +7.2%	$32.00 ➝ $36.00	Outperform
B Barrick Mining	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.37 +7.2%		Market Perform
B Barrick Mining	Upgraded by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.37 +7.2%		Sector Perform ➝ Outperform
BB BlackBerry	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.41 +4.6%	$4.00	Sector Perform
BBNX Beta Bionics	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.90 +2.0%	$21.00 ➝ $28.00	Buy
BIDU Baidu	Target Raised by	Nomura Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$136.63 +0.9%	$91.00 ➝ $135.00	Neutral
BKS Beeks Financial Cloud Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 209.75 -2.0%	GBX 335	Buy
BMO Bank of Montreal	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$179.14 -0.4%	C$173.00	Outperform
BNS Bank of Nova Scotia	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$89.06 -0.6%	C$81.00	Sector Perform
BNTX BioNTech	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Fye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$98.72 +2.6%	$116.00 ➝ $121.00	Neutral
BPOP Popular	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timur Braziler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.98 -0.8%	$140.00 ➝ $150.00	Overweight
BTDR Bitdeer Technologies Group	Target Raised by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Darren Aftahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.96 +9.2%	$18.00 ➝ $40.00	Buy
BZ KANZHUN	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.76 -2.1%		Buy
CAT Caterpillar	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$471.97 +1.2%	$500.00 ➝ $540.00
CCCC C4 Therapeutics	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.61 -17.4%	$10.00	Overweight

CCCC C4 Therapeutics	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sudan Loganathan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.61 -17.4%	$6.00	Overweight
CCI Crown Castle	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Rosivach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.19 +0.6%	$114.00	Peer Perform ➝ Outperform
CCO Cameco	Upgraded by	President Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$119.23 -0.1%	C$126.92	Neutral ➝ Buy
CCP Celtic	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 175 +4.5%	GBX 208 ➝ GBX 212	Buy
CDTX Cidara Therapeutics	Reiterated by	WBB Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$75.47 +9.8%		Strong-Buy
CDTX Cidara Therapeutics	Target Raised by	WBB Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Brozak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.47 +9.8%	$45.00 ➝ $123.00	Strong-Buy
CELC Celcuity	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Canino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.49 +1.2%		Buy
CLW Clearwater Paper	Initiated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.62 +7.5%		Buy
CLW Clearwater Paper	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Steuart Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.62 +7.5%	$30.00	Buy
CLW Clearwater Paper	Target Set by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.62 +7.5%	$30.00	Buy
CLYM Climb Bio	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.32 +0.4%	$7.00	Buy
CM Canadian Imperial Bank of Commerce	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$112.39 -0.1%	C$110.00	Sector Perform
CMCSA Comcast	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.49 -0.3%	$50.00 ➝ $44.00	Buy
COP ConocoPhillips	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$92.11 +0.2%	$113.00 ➝ $115.00	Outperform
CRC California Resources	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kalei Akamine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.72 -0.5%	$60.00 ➝ $66.00	Buy
CROX Crocs	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.14 -4.0%	$95.00 ➝ $75.00	Overweight ➝ Neutral
CRWD CrowdStrike	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$493.14 -1.9%	$430.00 ➝ $500.00	Hold
CSAN Cosan	Reiterated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lilyanna Yang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.63 -18.3%	$4.40	Hold ➝ Reduce
CSL Carlisle Companies	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$337.69 -0.1%	$380.00 ➝ $350.00	Hold
CTMX CytomX Therapeutics	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Brayer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.06 +4.0%	$6.00	Overweight
CTMX CytomX Therapeutics	Upgraded by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Brayer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.06 +4.0%		Strong-Buy
CVS CVS Health	Target Raised by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$75.28 +0.5%	$80.00 ➝ $85.00	Outperform
CYTK Cytokinetics	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Mamtani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.25 -0.8%	$74.00 ➝ $80.00	Buy
CYTK Cytokinetics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.25 -0.8%	$120.00	Buy
DD DuPont de Nemours	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aleksey Yefremov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.33 +0.3%	$92.00 ➝ $93.00	Overweight
DHR Danaher	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derik De Bruin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$190.30 -1.5%	$230.00 ➝ $220.00	Buy
EAT Brinker International	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zachary Fadem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$138.52 +1.6%	$165.00 ➝ $175.00	Equal Weight ➝ Overweight
EG Everest Group	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Peters Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$335.59 +0.1%		Strong-Buy ➝ Moderate Buy
EG Everest Group	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Peters Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$335.59 +0.1%	$410.00 ➝ $375.00	Strong-Buy ➝ Outperform
EQT EQT	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.89 +1.4%	$62.00 ➝ $60.00	Outperform
EVTL Vertical Aerospace	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Moeller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.29 +9.7%	$11.00	Buy
EW Edwards Lifesciences	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Wise Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.80 -0.8%	$95.00 ➝ $85.00	Buy
EXE Extendicare	Target Set by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$14.07 +4.8%	C$18.00	Outperform
EZJ easyJet	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 460.27 +2.9%		Buy
FDS FactSet Research Systems	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Kramm Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$295.52 +2.2%	$480.00 ➝ $425.00	Neutral ➝ Buy
FDX FedEx	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vernon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$230.40 -0.6%	$247.00 ➝ $250.00	Market Perform
FDX FedEx	Target Raised by	Daiwa Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$230.40 -0.6%	$232.00 ➝ $240.00	Neutral
FLYW Flywire	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Nabhan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.14 +0.2%	$13.00	Equal Weight
FVR FrontView REIT	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Paolone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.56 -1.5%	$12.00 ➝ $15.00	Neutral
GATX GATX	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Mohr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.41 +2.5%		Strong-Buy
GATX GATX	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Mohr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.41 +2.5%	$201.00	Buy
GDYN Grid Dynamics	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.11 +7.7%	$11.00	Buy
GDYN Grid Dynamics	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.11 +7.7%		Strong-Buy
GE GE Aerospace	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$300.91 -0.1%	$320.00 ➝ $350.00	Buy
GFR Greenfire Resources	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.88 -3.0%		Outperform ➝ Market Perform
GH Guardant Health	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.78 +1.1%		Strong-Buy
GH Guardant Health	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.78 +1.1%	$72.00	Overweight
GH Guardant Health	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Massaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.78 +1.1%	$70.00	Buy
GKOS Glaukos	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.74 +1.5%	$126.00 ➝ $120.00	Buy
GM General Motors	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ward Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.94 -0.1%	$61.00 ➝ $75.00	Buy

GOOG Alphabet	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$252.88 -0.9%	$215.00 ➝ $275.00	Outperform
GOOGL Alphabet	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Sebastian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$252.53 -0.9%	$215.00 ➝ $275.00	Outperform
GOOGL Alphabet	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Youssef Squali Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$252.53 -0.9%	$225.00 ➝ $285.00	Buy
HALO Halozyme Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.28 +0.6%	$75.00 ➝ $85.00	Buy
HCM HUTCHMED	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Lin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.66 -2.2%	$18.00 ➝ $13.75	Equal Weight ➝ Underweight
HGTY Hagerty	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Zaremski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.25 -3.7%		Hold
HGTY Hagerty	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Zaremski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.25 -3.7%	$13.00	Market Perform
HOUS Anywhere Real Estate	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Paolone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.30 +45.7%	$10.00	Underweight ➝ Neutral
HP Helmerich & Payne	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.27 +3.6%	$17.00 ➝ $25.00	Equal Weight ➝ Overweight
HP Helmerich & Payne	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.27 +3.6%		Hold ➝ Strong-Buy
HSAI Hesai Group	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tina Hou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.71 +2.3%	$26.30 ➝ $36.00	Buy
HSBC HSBC	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$70.02 +0.4%		Buy
HST Host Hotels & Resorts	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.17 -1.4%	$17.00 ➝ $18.00	Neutral
HTFL Heartflow	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Plovanic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.43 -4.4%	$35.00 ➝ $39.00	Buy
HUM Humana	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Elizabeth Suzuki Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.09 +2.1%	$295.00	In-Line
IDCC InterDigital	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$346.49 +3.5%		Outperform
IFF International Flavors & Fragrances	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa De Neve Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.21 -2.1%	$92.00 ➝ $90.00	Overweight
IMAX IMAX	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alicia Reese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.64 +2.1%	$35.00 ➝ $39.00	Outperform
IMIAY IMI	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.20		Buy
IMNM Immunome	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salveen Richter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.77 +4.0%		Strong-Buy
IMNM Immunome	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salveen Richter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.77 +4.0%	$26.00	Buy
INCY Incyte	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Willey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.73 -2.1%	$110.00 ➝ $115.00	Buy
INFU InfuSystem	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Haynor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.41 +4.1%	$15.00	Buy
INSP Inspire Medical Systems	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danielle Antalffy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.96 -1.2%	$230.00 ➝ $89.00	Buy ➝ Neutral
INSP Inspire Medical Systems	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danielle Antalffy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.96 -1.2%		Strong-Buy ➝ Hold
INTC Intel	Upgraded by	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$28.76 -2.8%		Sell ➝ Hold
IONQ IonQ	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.90 +2.1%	$75.00 ➝ $100.00	Buy
IONS Ionis Pharmaceuticals	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Nachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.36 +0.6%	$75.00	Strong-Buy
IRM Iron Mountain	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Petersen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.42 +4.5%		Strong-Buy
IRM Iron Mountain	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Petersen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.42 +4.5%	$120.00	Buy
JBSS John B. Sanfilippo & Son	Initiated by	BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.25 +1.6%	$109.00	Buy
JMHLY Jardine Matheson	Upgraded by	Macquarie Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.34 +4.6%		Hold ➝ Strong-Buy
JSPR Jasper Therapeutics	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Silvan Tuerkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.54 +1.4%	$12.00 ➝ $6.00	Market Outperform
JSPR Jasper Therapeutics	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Clark-Gartner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.54 +1.4%	$20.00 ➝ $14.00	Outperform
JSPR Jasper Therapeutics	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Zelin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.54 +1.4%	$20.00 ➝ $7.00	Buy
KDP Keurig Dr Pepper	Downgraded by	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Grundy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.95 -4.3%		Neutral ➝ Underperform
KDP Keurig Dr Pepper	Downgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.95 -4.3%		Neutral ➝ Underperform
KEX Kirby	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Mohr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.85 +2.1%		Hold
KEX Kirby	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Mohr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.85 +2.1%	$91.00	Neutral
KLAC KLA	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shane Brett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,071.25 +2.5%	$928.00 ➝ $1,093.00	Overweight ➝ Equal Weight
KMB Kimberly-Clark	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Javier Escalante Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$124.07 -0.4%	$155.00 ➝ $150.00	Outperform
KOD Kodiak Sciences	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Maury Raycroft Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.01 +57.5%	$15.00	Buy
KOS Kosmos Energy	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Neil Mehta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.69 -0.3%	$3.00 ➝ $2.00	Buy ➝ Neutral
LEN Lennar	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Lovallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%	$146.00 ➝ $161.00	Buy
LEN Lennar	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rehaut Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%	$97.00 ➝ $92.00	Neutral
LEN Lennar	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$121.90 -4.3%	$98.00 ➝ $106.00	Sector Perform
LEN Lennar	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Buck Horne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%		Market Perform ➝ Underperform
LEN Lennar	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%	$130.00 ➝ $140.00	Market Perform ➝ Market Outperform
LEN Lennar	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay McCanless Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%	$130.00	Neutral
LEN Lennar	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%	$114.00 ➝ $118.00	In-Line

LEN Lennar	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Pettinari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%		Outperform
LEN Lennar	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Pettinari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.90 -4.3%	$116.00 ➝ $133.00	Neutral
LINE Lineage	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Kamdem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.40 +0.0%	$50.00 ➝ $46.00	Equal Weight
LITE Lumentum	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Genovese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.71 -2.4%	$150.00 ➝ $225.00	Buy
LRCX Lam Research	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shane Brett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.20 +4.2%	$92.00 ➝ $125.00	Underweight ➝ Equal Weight
LSCC Lattice Semiconductor	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Bolton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.71 +3.6%	$70.00 ➝ $80.00	Buy
LTH Lithium Ionic	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$0.72 -2.7%	C$1.25 ➝ C$1.50	Outperform
LYFT Lyft	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel L. Kurnos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.63 +0.2%	$20.00 ➝ $26.00	Buy
LYG Lloyds Banking Group	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.47 +0.3%		Neutral
MBX MBX Biosciences	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.00 +100.0%		Outperform
MBX MBX Biosciences	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.00 +100.0%		Buy
MBX MBX Biosciences	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trevor Allred Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.00 +100.0%		Outperform
MCY Mercury General	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C. Gregory Peters Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.06 +3.2%	$90.00 ➝ $100.00	Strong-Buy
MDB MongoDB	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$323.59 +0.0%	$340.00 ➝ $375.00	Buy
MGM MGM Resorts International	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Chaiken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.55 -3.5%	$58.00 ➝ $56.00	Outperform
MP MP Materials	Target Set by	Daiwa Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dennis Ip Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.19 0.0%	$80.00	Outperform
MTD Mettler-Toledo International	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derik De Bruin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,257.79 -0.6%	$1,260.00 ➝ $1,390.00	Neutral
MU Micron Technology	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.62 +1.2%	$145.00 ➝ $173.00	Buy
MU Micron Technology	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.62 +1.2%	$135.00 ➝ $160.00	Equal Weight
MYO Myomo	Target Lowered by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.85 -2.3%	$11.50 ➝ $10.50	Buy
NB NioCorp Developments	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.99 +2.0%	$4.00 ➝ $8.25	Buy
NBIX Neurocrine Biosciences	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.62 +1.0%	$161.00 ➝ $170.00	Buy
NBIX Neurocrine Biosciences	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.62 +1.0%		Outperform
NBR Nabors Industries	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.98 +3.6%	$29.00 ➝ $36.00	Underweight
NEM Newmont	Reiterated by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$83.74 +2.5%		Outperform
NGT Newmont	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$115.73 +3.0%	C$110.00 ➝ C$125.00	Outperform
NRG NRG Energy	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Weisel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$171.11 +4.1%	$212.00	Sector Outperform
NTRA Natera	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$179.19 -1.1%	$175.00	Equal Weight
NTRA Natera	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$179.19 -1.1%		Hold
NVDA NVIDIA	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$183.61 +3.9%		Overweight
NVDA NVIDIA	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$183.61 +3.9%	$210.00
OKLO Oklo	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.08 +3.6%	$80.00 ➝ $150.00	Outperform
ORCL Oracle	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$329.10 +6.6%		Outperform
ORI Old Republic International	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C. Gregory Peters Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.94 +2.8%	$43.00 ➝ $47.00	Outperform ➝ Strong-Buy
OTLK Oncobiologics	Target Lowered by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.97 +0.5%	$21.00 ➝ $8.00	Buy
PAYC Paycom Software	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jared Levine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.08 +1.6%	$246.00 ➝ $258.00	Hold ➝ Buy
PAYX Paychex	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.40 +0.3%	$152.00 ➝ $142.00	Hold
PETS Pets at Home Group	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 202.80 +2.2%	GBX 285 ➝ GBX 245	Buy
PGR Progressive	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$241.26 -0.4%	$267.00 ➝ $265.00	Equal Weight
PGRE Paramount Group	Downgraded by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.54 +0.1%		Strong-Buy ➝ Hold
PGRE Paramount Group	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.54 +0.1%	$6.60	Outperform ➝ In-Line
PLXS Plexus	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.62 +1.9%	$160.00 ➝ $165.00	Buy
PLXS Plexus	Target Set by	Williams Trading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.62 +1.9%	$165.00
PPH PPHE Hotel Group	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,322 +0.9%	GBX 1,700 ➝ GBX 1,600	Buy
PPTA Perpetua Resources	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.86 +3.0%		Buy
PRCH Porch Group	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Helfstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.89 +0.2%	$17.00 ➝ $25.00	Outperform
PRIM Primoris Services	Initiated by	Glj Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Wang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.22 +3.4%	$160.00	Buy
PRU Prudential	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,027.50 -0.2%	GBX 1,350	Buy
PSX Phillips 66	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.86 +0.1%	$143.00 ➝ $150.00	Buy
QBTS D-Wave Quantum	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.65 -4.6%	$22.00 ➝ $33.00	Buy

R Ryder System	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Mohr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.03 +0.7%	$217.00	Buy
RBLX Roblox	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cory Carpenter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$136.88 +1.3%	$150.00 ➝ $160.00	Overweight
RBW Rainbow Rare Earths	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 17.84 +3.4%	GBX 34	Buy
RGEN Repligen	Upgraded by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Markowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$125.94 +3.0%	$130.00 ➝ $155.00	In-Line ➝ Outperform
RGTI Rigetti Computing	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.37 -0.5%	$19.00 ➝ $35.00	Buy
RJF Raymond James Financial	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Allen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$175.44 +0.8%	$170.00 ➝ $180.00	Neutral
RNA Avidity Biosciences	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.34 +3.1%	$70.00 ➝ $65.00	Outperform
RNTX Rein Therapeutics	Upgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.18 -2.5%		Strong-Buy
RNTX Rein Therapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.18 -2.5%	$10.00	Buy
RVTY Revvity	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ryskin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.38 -0.4%	$110.00 ➝ $99.00	Buy
RY Royal Bank Of Canada	Upgraded by	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$148.72 +1.0%		Hold ➝ Buy
RY Royal Bank of Canada	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$205.50 +1.2%	C$203.00	Sector Perform
RZLT Rezolute	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Debjit Chattopadhyay Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.14 +5.7%	$15.00	Buy
SCBFF Standard Chartered	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.19 -1.7%		Neutral
SGHC Super Group (SGHC)	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.92 +9.8%		Outperform
SGHC Super Group (SGHC)	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.92 +9.8%	$15.00	Buy
SGHC Super Group (SGHC)	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.92 +9.8%	$15.00 ➝ $16.00	Market Outperform
SHOO Steven Madden	Upgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.16 +3.6%	$25.00 ➝ $40.00	Neutral ➝ Overweight
SINT Sintx Technologies	Target Lowered by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.71 -4.5%	$28.00 ➝ $25.00	Buy
SKIN Beauty Health	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.28		Hold
SKIN Beauty Health	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.28	$2.00 ➝ $2.50	Hold
SRPT Sarepta Therapeutics	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kostas Biliouris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.65 +7.0%	$50.00	Market Perform ➝ Outperform
SSL Sasol	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.23 -6.3%		Overweight ➝ Equal Weight
STX Seagate Technology	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.33 +3.7%	$175.00 ➝ $280.00	Overweight
SVM Silvercorp Metals	Target Set by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew O'Keefe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.11 +17.3%	$7.50	Overweight
TATYY Tate & Lyle	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.81 -6.5%		Underweight
TD Toronto-Dominion Bank	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$109.56 +1.1%	C$100.00	Sector Perform
TER Teradyne	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mehdi Hosseini Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.18 +12.8%	$133.00 ➝ $200.00	Positive
TLN Talen Energy	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Weisel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$429.72 +1.5%	$418.00	Sector Perform
TOST Toast	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Koning Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.94 -5.3%	$48.00
TSLA Tesla	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Potter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$434.21 +1.9%	$400.00 ➝ $500.00	Overweight
UIS Unisys	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.11 +2.2%	$4.00	Hold
URI United Rentals	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tami Zakaria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$943.48 +0.2%	$1,000.00 ➝ $1,150.00	Overweight
USAU US Gold	Target Raised by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.33 +2.5%	$19.00 ➝ $20.00	Buy
V Visa	Downgraded by	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$344.28 +0.8%		Buy ➝ Hold
VKTX Viking Therapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Zelin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.25 +3.3%	$125.00	Buy
VLO Valero Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$166.52 +2.4%	$165.00 ➝ $183.00	Buy
VST Vistra	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.88 +3.1%		Buy ➝ Hold
VST Vistra	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Weisel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.88 +3.1%	$256.00	Sector Outperform
WAB Wabtec	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Mohr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$197.97 +4.9%		Strong-Buy
WAB Wabtec	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Mohr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$197.97 +4.9%	$225.00	Buy
WBD Warner Bros. Discovery	Target Raised by	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.64 +1.6%	$14.00 ➝ $23.00	Buy
WBD Warner Bros. Discovery	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurent Yoon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.64 +1.6%	$13.00 ➝ $16.00	Market Perform
WIL Wilmington	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 329.10 -1.8%	GBX 460	Buy
WIL Wilmington	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 329.10 -1.8%	GBX 450	Buy
WTW Willis Towers Watson Public	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C. Gregory Peters Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$338.85 +0.6%	$380.00 ➝ $400.00	Strong-Buy
XEL Xcel Energy	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Thalacker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.35 +0.3%	$73.00 ➝ $80.00	Market Perform ➝ Outperform
ZETA Zeta Global	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.11 +2.9%	$25.00 ➝ $27.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:13 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings